Skip to content

Clinical trials

Phase 4 Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 4 Clear all

280 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20024
20037
20043
200511
200611
200713
200811
20096
201010
201110
20127
201312
201411
20157
201618
20177
201810
201911
202011
202117
202218
202311
202418
202513
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed136
Unknown status56
Recruiting34
Not yet recruiting19
Terminated18
Withdrawn10
Active, not recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Hospital Research Institute18
Novartis Pharmaceuticals13
Hoffmann-La Roche11
AstraZeneca7
Institut Claudius Regaud5
Eli Lilly and Company4
Fudan University4
Memorial Sloan Kettering Cancer Center4
Novartis4
Second Affiliated Hospital, Zhejiang University, School of Medicine4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms280
Postoperative Pain14
Neoplasm Metastasis12
Neoplasms9
Prostatic Neoplasms9
Ovarian Neoplasms7
Osteoporosis6
Pain6
Cardiotoxicity5
Colorectal Neoplasms5

Trials

Showing 76 to 100 of 280. Each trial links to its page on Pharma Observatory.

180 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.